Could a common diuretic protect hearts in rare ARVD?
NCT ID NCT03593317
First seen Feb 24, 2026 · Last updated May 21, 2026 · Updated 15 times
Summary
This study tests whether spironolactone, a medication that blocks certain hormones, can slow the worsening of heart function and reduce dangerous heart rhythms in people with arrhythmogenic right ventricular dysplasia (ARVD), a rare genetic heart disease. About 120 adults with ARVD will receive either spironolactone or a placebo for up to 3 years. The goal is to see if the drug can prevent heart damage and improve quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Amiens Picardie
NOT_YET_RECRUITINGAmiens, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU Dijon
RECRUITINGDijon, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Groupe Hospitalo Universitaire Caremeau
NOT_YET_RECRUITINGNîmes, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hôpital Arnaud de Villeneuve
RECRUITINGMontpellier, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hôpital Cardiologique Louis Pradel
RECRUITINGBron, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Gabriel Montpied
NOT_YET_RECRUITINGClermont-Ferrand, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hôpital Laennec
RECRUITINGNantes, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hôpital Michallon
NOT_YET_RECRUITINGGrenoble, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hôpital Pitié Salpetrière
RECRUITINGParis, France
Contact
Contact Email: •••••@•••••
-
Hôpital Rangueil
NOT_YET_RECRUITINGToulouse, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hôpital de Haut-Lévêque
NOT_YET_RECRUITINGPessac, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hôpital de la Timone
NOT_YET_RECRUITINGMarseille, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Nouvel Hôpital Civil
NOT_YET_RECRUITINGStrasbourg, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.